Andreas Munk Petersen
Overview
Explore the profile of Andreas Munk Petersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wronding T, Vomstein K, Bosma E, Mortensen B, Westh H, Heintz J, et al.
EClinicalMedicine
. 2023 Aug;
61:102070.
PMID: 37528843
Background: Vaginal dysbiosis covers imbalances in the vaginal microbiota, defined by altered composition of bacteria, viruses, and fungi and is associated with euploid pregnancy losses, premature birth, infertility, or bacterial...
12.
Halkjaer S, Lo B, Cold F, Hojer Christensen A, Holster S, Konig J, et al.
World J Gastroenterol
. 2023 Jun;
29(20):3185-3202.
PMID: 37346153
Background: Irritable bowel syndrome (IBS) is the most prevalent gastrointestinal disorder in developed countries and reduces patients' quality of life, hinders their ability to work, and increases health care costs....
13.
Knudsen M, Rubin I, Petersen A
Drug Healthc Patient Saf
. 2023 Mar;
15:63-71.
PMID: 36974197
Introduction: The aim of this systematic review of randomized clinical trials (RCTs) was to examine the efficacy, safety, and tolerability of vancomycin for treatment of recurrent infection (rCDI). Methods: The...
14.
Wewer M, Arp L, Sarikaya M, Felding O, Vind I, Pedersen G, et al.
Crohns Colitis 360
. 2023 Feb;
4(4):otac041.
PMID: 36778517
Background: Patients with inflammatory bowel disease (IBD) who receive biologicals frequently experience lack or loss of response. Our aim was to describe the use and efficacy of biological therapy in...
15.
Persson S, Nielsen H, Coia J, Engberg J, Olesen B, Engsbro A, et al.
Euro Surveill
. 2023 Jan;
27(49).
PMID: 36695439
BackgroundSince 2008, Danish national surveillance of has focused on binary toxin-positive strains in order to monitor epidemic types such as PCR ribotype (RT) 027 and 078. Additional surveillance is needed...
16.
Svensson C, Cold F, Ribberholt I, Zangenberg M, Mirsepasi-Lauridsen H, Petersen A, et al.
Cells
. 2022 Oct;
11(20).
PMID: 36291139
The most effective treatment for recurrent infection (CDI) is faecal microbiota transplantation (FMT); however, the optimal route of administration is thus far unknown. This retrospective cohort study of 343 patients...
17.
Rubin I, Mollerup S, Broholm C, Baker A, Holm M, Pedersen M, et al.
Appl Environ Microbiol
. 2022 Sep;
88(19):e0108722.
PMID: 36165644
Synbiotics combine probiotics and prebiotics and are being investigated for potential health benefits. In this single-group-design trial, we analyzed changes in the gut microbiome, stool quality, and gastrointestinal well-being in...
18.
19.
Rubin I, Mollerup S, Broholm C, Knudsen S, Baker A, Helms M, et al.
Microbiol Spectr
. 2022 Apr;
10(3):e0234821.
PMID: 35475684
The purpose of this trial was to evaluate the efficacy of a 4-week supplementation of Lactobacillus rhamnosus GG (LGG) in eliminating the gastrointestinal carrier state of vancomycin-resistant Enterococcus faecium (VREfm)...
20.
Mirsepasi-Lauridsen H, Vranckx K, Nielsen H, Andersen L, Archampong T, Krogfelt K, et al.
Front Cell Infect Microbiol
. 2022 Apr;
12:832500.
PMID: 35372093
Background: Ulcerative colitis (UC) is a relapsing nontransmural inflammatory disease that is restricted to the colon and is characterized by flare-ups of bloody diarrhea. In this study, we aimed to...